GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Days Sales Outstanding

Wai Yuen Tong Medicine Holdings (HKSE:00897) Days Sales Outstanding : 18.09 (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Days Sales Outstanding?

Wai Yuen Tong Medicine Holdings's average Accounts Receivable for the six months ended in Sep. 2023 was HK$67 Mil. Wai Yuen Tong Medicine Holdings's Revenue for the six months ended in Sep. 2023 was HK$679 Mil. Hence, Wai Yuen Tong Medicine Holdings's Days Sales Outstanding for the six months ended in Sep. 2023 was 18.09.

The historical rank and industry rank for Wai Yuen Tong Medicine Holdings's Days Sales Outstanding or its related term are showing as below:

HKSE:00897' s Days Sales Outstanding Range Over the Past 10 Years
Min: 15.3   Med: 48.57   Max: 76.21
Current: 16.85

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest Days Sales Outstanding was 76.21. The lowest was 15.30. And the median was 48.57.

HKSE:00897's Days Sales Outstanding is ranked better than
93.78% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs HKSE:00897: 16.85

Wai Yuen Tong Medicine Holdings's Days Sales Outstanding increased from Sep. 2022 (17.61) to Sep. 2023 (18.09).


Wai Yuen Tong Medicine Holdings Days Sales Outstanding Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Days Sales Outstanding Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.95 48.40 19.85 15.30 18.64

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.24 17.52 17.61 16.32 18.09

Competitive Comparison of Wai Yuen Tong Medicine Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wai Yuen Tong Medicine Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's Days Sales Outstanding falls into.



Wai Yuen Tong Medicine Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Wai Yuen Tong Medicine Holdings's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (63.346 + 68.028) / 2 ) / 1286.428*365
=65.687 / 1286.428*365
=18.64

Wai Yuen Tong Medicine Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (68.028 + 66.566) / 2 ) / 678.804*365 / 2
=67.297 / 678.804*365 / 2
=18.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Wai Yuen Tong Medicine Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines